CNY 185.3
(2.95%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 323.9 Million | 200.53 Million | 245.24 Million | 235.03 Million | 164.35 Million | 135.54 Million |
Net Income | 310.71 Million | 153.5 Million | 281.69 Million | 251.48 Million | 174.06 Million | 142.51 Million |
Depreciation & Amortization | 5.49 Million | 4.33 Million | 3.58 Million | 2.01 Million | 1.71 Million | 2.4 Million |
Deferred income taxes | -3.97 Million | -15.4 Million | -444.14 | 1.3 Million | 175.85 Thousand | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -54.5 Million | -25.78 Million | 11.33 Million | 19.61 Million | -2.29 Million | -6.91 Million |
Other non-cash items | 131.66 Million | 68.48 Million | -51.37 Million | -38.07 Million | -9.12 Million | -2.46 Million |
Investing Cash Flow | -167.47 Million | -59.44 Million | -388.58 Million | -2.11 Billion | 49.26 Million | -47.1 Million |
Investments in PPE | -19.59 Million | -24.6 Million | -2.27 Million | -2.52 Million | -8.09 Million | -660.86 Thousand |
Acquisitions | 4000.00 | 1 Million | 0.74 | 2.52 Million | 8.1 Million | - |
Investment purchases | -3.48 Billion | -2.81 Billion | -5.42 Billion | -5.05 Billion | -23 Million | -91 Million |
Sales/Maturities of investments | 3.33 Billion | 2.78 Billion | 5.03 Billion | 2.94 Billion | 80.35 Million | 44.55 Million |
Other Investing Activities | -1.00 | -999.99 Thousand | - | -2.52 Million | -8.09 Million | 0.91 |
Financing Cash Flow | -48.5 Million | -93.73 Million | -67.88 Million | 1.67 Billion | -52.8 Million | -50 Million |
Debt repayment | -80 Million | -1.39 Million | -1.21 Million | - | - | - |
Dividends payments | -46.66 Million | -93.33 Million | -66.67 Million | -40 Million | -50 Million | -50 Million |
Common Stock Repurchased | - | - | 2.42 Million | - | - | - |
Common Stock Issuance | - | - | -1.21 Million | -78.36 Million | -2.8 Million | - |
Other Financing Activities | 78.15 Million | 999.99 Thousand | -1.21 Million | 1.71 Billion | -2.8 Million | -50 Million |
Accounts receivables | -48.88 Million | -36.34 Million | -9.69 Million | 7.71 Million | -8.76 Million | -3.71 Million |
Accounts payables | -9.04 Million | 30.86 Million | 20.52 Million | 24.05 Million | -2.67 Million | - |
Inventory | 3.42 Million | -4.9 Million | 513.56 Thousand | -894.8 Thousand | 9.25 Million | - |
Other working capital | -13.01 Million | -15.4 Million | -444.00 | -11.25 Million | -111.83 Thousand | -798.85 Thousand |
Cash at beginning of period | 608.83 Million | 557.22 Million | 769.57 Million | 977.14 Million | 815.56 Million | 775.23 Million |
Cash at end of period | 717.43 Million | 608.83 Million | 557.22 Million | 769.57 Million | 977.14 Million | 815.56 Million |
Capital Expenditure | -19.59 Million | -24.6 Million | -2.27 Million | -2.52 Million | -8.09 Million | -660.86 Thousand |
Effect of forex changes on cash | 677.59 Thousand | 4.25 Million | -1.12 Million | -2.83 Million | 758.05 Thousand | 1.9 Million |
Net cash flow / Change in cash | 108.59 Million | 51.61 Million | -212.35 Million | -207.57 Million | 161.57 Million | 40.33 Million |
Free Cash Flow | 304.31 Million | 175.93 Million | 242.97 Million | 232.51 Million | 156.25 Million | 134.88 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 43.62 Million | 50.19 Million | 50.19 Million | 310.71 Million | 112.53 Million | 79.45 Million |
Depreciation & Amortization | - | 1.2 Million | 1.2 Million | 5.49 Million | 806.35 Thousand | -3.65 Million |
Deferred income taxes | - | - | - | -3.97 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 11.44 Million | - | -54.5 Million | -45.46 Million | -13.47 Million |
Other non-cash items | 1.18 Million | 21.68 Million | -39.33 Million | 131.66 Million | 31.83 Million | 5.11 Million |
Investing Cash Flow | 107.56 Million | 84.25 Million | -395.74 Million | -167.47 Million | 10.32 Million | -178.13 Million |
Investments in PPE | -7.44 Million | -14.33 Million | -15.89 Million | -19.59 Million | -8.89 Million | -6.08 Million |
Acquisitions | - | -200 Thousand | -594 Million | 4000.00 | 4000.00 | 0.10 |
Investment purchases | -1.46 Billion | -1.26 Billion | -387.94 Million | -3.48 Billion | -324.11 Million | -1.32 Billion |
Sales/Maturities of investments | 1.58 Billion | 1.36 Billion | 602.09 Million | 3.33 Billion | 343.33 Million | 1.15 Billion |
Other Investing Activities | - | 125.97 Million | 214.14 Million | -1.00 | -1.00 | - |
Financing Cash Flow | -50.83 Million | -106.36 Million | 119.66 Million | -48.5 Million | -30.64 Million | 29.55 Million |
Debt repayment | -120 Million | - | -120 Million | -80 Million | -30 Million | - |
Dividends payments | - | -106.01 Million | - | -46.66 Million | -46.66 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 69.16 Million | -105.68 Million | -330.13 Thousand | 78.15 Million | 46.02 Million | 29.55 Million |
Accounts receivables | - | 10.46 Million | - | -48.88 Million | -48.88 Million | -14.41 Million |
Accounts payables | - | - | - | -9.04 Million | - | - |
Inventory | - | 977.66 Thousand | - | 3.42 Million | 3.42 Million | 940.46 Thousand |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 500.9 Million | 452.21 Million | 717.43 Million | 608.83 Million | 592.73 Million | 673.94 Million |
Cash at end of period | 602.18 Million | 500.9 Million | 452.21 Million | 717.43 Million | 717.43 Million | 592.73 Million |
Capital Expenditure | -7.44 Million | -14.33 Million | -15.89 Million | -19.59 Million | -8.89 Million | -6.08 Million |
Effect of forex changes on cash | - | 125.73 Thousand | 7601.17 | 677.59 Thousand | -153.87 Thousand | -62.03 Thousand |
Net cash flow / Change in cash | 101.27 Million | 48.69 Million | -265.21 Million | 108.59 Million | 124.69 Million | -81.2 Million |
Free Cash Flow | 37.36 Million | 56.34 Million | -5.03 Million | 304.31 Million | 136.27 Million | 61.34 Million |
HGH
ILM1
CVSI
IEM
300702
3652